Humana Inc (NYSE:HUM) Shares Bought by LPL Financial LLC

LPL Financial LLC raised its position in Humana Inc (NYSE:HUM) by 13.4% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 15,812 shares of the insurance provider’s stock after buying an additional 1,872 shares during the period. LPL Financial LLC’s holdings in Humana were worth $4,195,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently bought and sold shares of HUM. Whittier Trust Co. acquired a new position in shares of Humana during the 2nd quarter valued at about $27,000. Next Capital Management LLC acquired a new stake in Humana during the second quarter worth about $27,000. Advantage Investment Management LLC increased its position in Humana by 287.1% during the second quarter. Advantage Investment Management LLC now owns 120 shares of the insurance provider’s stock worth $32,000 after purchasing an additional 89 shares during the last quarter. Coastal Investment Advisors Inc. increased its position in Humana by 1,110.0% during the second quarter. Coastal Investment Advisors Inc. now owns 121 shares of the insurance provider’s stock worth $33,000 after purchasing an additional 111 shares during the last quarter. Finally, Harel Insurance Investments & Financial Services Ltd. purchased a new position in Humana during the second quarter worth about $36,000. Institutional investors own 92.90% of the company’s stock.

In related news, insider Brian P. Leclaire sold 7,239 shares of the business’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $289.70, for a total value of $2,097,138.30. Following the sale, the insider now owns 12,994 shares in the company, valued at approximately $3,764,361.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.54% of the stock is currently owned by insiders.

Several equities analysts have weighed in on HUM shares. UBS Group boosted their target price on shares of Humana from $266.00 to $317.00 and gave the company a “neutral” rating in a report on Thursday, August 1st. Morgan Stanley raised their price target on shares of Humana from $315.00 to $342.00 and gave the stock an “overweight” rating in a report on Friday, August 23rd. SunTrust Banks lifted their price target on shares of Humana to $340.00 and gave the company a “hold” rating in a research report on Thursday, August 1st. Cantor Fitzgerald upgraded Humana from a “neutral” rating to an “overweight” rating and upped their price objective for the company from $300.00 to $345.00 in a report on Monday, August 12th. Finally, JPMorgan Chase & Co. increased their price objective on Humana from $288.00 to $322.00 and gave the stock an “overweight” rating in a research report on Thursday, August 1st. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fourteen have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $341.95.

Shares of HUM stock traded down $1.59 during trading hours on Wednesday, hitting $275.26. The company had a trading volume of 22,344 shares, compared to its average volume of 877,683. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.75 and a quick ratio of 1.75. The stock has a market capitalization of $37.24 billion, a PE ratio of 18.95, a price-to-earnings-growth ratio of 1.19 and a beta of 0.84. The company’s fifty day moving average is $287.24 and its 200 day moving average is $269.54. Humana Inc has a fifty-two week low of $225.65 and a fifty-two week high of $355.88.

Humana (NYSE:HUM) last posted its earnings results on Wednesday, July 31st. The insurance provider reported $6.05 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $5.24 by $0.81. The firm had revenue of $16.25 billion during the quarter, compared to the consensus estimate of $15.88 billion. Humana had a net margin of 4.13% and a return on equity of 22.47%. The firm’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same quarter last year, the firm earned $3.96 EPS. Equities analysts forecast that Humana Inc will post 17.63 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a $0.55 dividend. The ex-dividend date is Friday, September 27th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.80%. Humana’s payout ratio is presently 15.12%.

About Humana

Humana Inc, together with its subsidiaries, operates as a health and well-being company in the United States. The company offers medical and supplemental benefit plans to individuals. It also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Story: What factors cause inflation to rise?

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.